Neurosciences articles for Mayo Clinic, United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 44

Article ‘Count’ for Neurosciences.

Journal Count Share
14 8.00
<atl>Diffusion scpMRI/scp and α‐Synuclein Seed Amplification Status in Parkinson's Disease</atl> 0.33
Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease 1.00
Population‐Based Epidemiology of Autoimmune Seizures and Epilepsies 0.90
Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism 0.89
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment 0.08
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.07
Novel Aggressive Subtype of Multiple System Atrophy Identified by Unsupervised Machine Learning 0.93
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.08
Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease 0.72
Thalamic Stimulation Induced Changes in Network Connectivity and Excitability in Epilepsy 0.95
Real‐World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease‐Modifying Therapy in Pediatric Multiple Sclerosis 0.07
scpMarkVCID2/scp Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics 0.09
Uncovering Image‐Driven Subtypes with Distinct Pathology and Clinical Course in Autopsy‐Confirmed Four Repeat Tauopathies 1.00
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia 0.89
2 0.13
Retrospective cohort study of Participant Characteristics and Outcomes of Advanced Postacute Brain Injury Rehabilitation for Brain Injury due to Hypoxia 0.05
Primary Care and Brain Injury Physician Utilization for Persons Living with Chronic Brain Injury 0.08
5 2.07
The deep brain stimulation response network in Parkinson’s disease operates in the high beta band 0.03
Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome 1.00
Brain signatures of nociplastic pain: Fibromyalgia Index and descending modulation at population level 0.04
Brain atrophy patterns in anti-IgLON5 disease 0.10
Artificial intelligence models using F-wave responses predict amyotrophic lateral sclerosis 0.90
1 0.21
Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS 0.21
1 0.71
Rod-shaped microglia interact with neuronal dendrites to attenuate cortical excitability during TDP-43-related neurodegeneration 0.71
1 0.09
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.09
2 0.97
Disruption of CSF-1 receptor-mediated metal ion homeostasis in the murine brain promotes neurodegenerative disease 0.10
Neutrophil-microglia interaction drives motor dysfunction in neuromyelitis optica model induced by subarachnoid AQP4-IgG 0.87
1 0.06
A cascade model of dynamic cerebral autoregulation 0.06
2 0.26
Population-scale repeat expansions elucidate disease risk and brain atrophy 0.18
Alzheimer’s risk allele causes aberrant lipid droplets in microglia 0.08
5 1.62
Genotype epigenome phenotype integration reveals peripheral immune contributions to type I bipolar disorder 0.54
Human cerebrospinal fluid net flow enhanced by respiration during the awake state 0.91
Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease 0.06
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification 0.08
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain 0.04
2 0.11
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD 0.08
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
1 0.59
Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition 0.59
1 0.20
Mapping epileptogenic brain using a unified spatial–temporal–spectral source imaging framework 0.20
1 0.04
Dynamic MRI of Fluid and Solute Transportation across the Arachnoid Barrier in the Human Meninges. 0.04
1 0.13
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.13
1 0.98
Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case–control study 0.98
1 0.10
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis 0.10
2 0.11
Zorevunersen in Children and Adolescents with Dravet Syndrome 0.06
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus 0.05

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.